| Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium IG McKeith, DW Dickson, J Lowe, M Emre, JT O'brien, H Feldman, ... Neurology 65 (12), 1863-1872, 2005 | 8977* | 2005 |
| Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria B Dubois, HH Feldman, C Jacova, ST DeKosky, P Barberger-Gateau, ... The Lancet Neurology 6 (8), 734-746, 2007 | 5713 | 2007 |
| Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia K Rascovsky, JR Hodges, D Knopman, MF Mendez, JH Kramer, ... Brain 134 (9), 2456-2477, 2011 | 5280 | 2011 |
| Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop IG McKeith, D Galasko, K Kosaka, EK Perry, DW Dickson, LA Hansen, ... Neurology 47 (5), 1113-1124, 1996 | 4852 | 1996 |
| Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ... The Lancet Neurology 13 (6), 614-629, 2014 | 3775 | 2014 |
| Revising the definition of Alzheimer's disease: a new lexicon B Dubois, HH Feldman, C Jacova, JL Cummings, ST DeKosky, ... The Lancet Neurology 9 (11), 1118-1127, 2010 | 2507 | 2010 |
| Vitamin E and donepezil for the treatment of mild cognitive impairment RC Petersen, RG Thomas, M Grundman, D Bennett, R Doody, S Ferris, ... New England Journal of Medicine 352 (23), 2379-2388, 2005 | 2490 | 2005 |
| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2469 | 2019 |
| Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease AC Naj, G Jun, GW Beecham, LS Wang, BN Vardarajan, J Buros, ... Nature genetics 43 (5), 436-441, 2011 | 2213 | 2011 |
| The ageing systemic milieu negatively regulates neurogenesis and cognitive function SA Villeda, J Luo, KI Mosher, B Zou, M Britschgi, G Bieri, TM Stan, ... Nature 477 (7362), 90-94, 2011 | 1932 | 2011 |
| The Parkinson progression marker initiative (PPMI) K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ... Progress in neurobiology 95 (4), 629-635, 2011 | 1653 | 2011 |
| Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors RN Kalaria, GE Maestre, R Arizaga, RP Friedland, D Galasko, K Hall, ... The Lancet Neurology 7 (9), 812-826, 2008 | 1581 | 2008 |
| An inventory to assess activities of daily living for clinical trials in Alzheimer's disease D Galasko, D Bennett, M Sano, C Ernesto, R Thomas, M Grundman, ... Alzheimer Disease & Associated Disorders 11, 33-39, 1997 | 1485 | 1997 |
| Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins S Ray, M Britschgi, C Herbert, Y Takeda-Uchimura, A Boxer, K Blennow, ... Nature medicine 13 (11), 1359-1362, 2007 | 1322 | 2007 |
| Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials M Grundman, RC Petersen, SH Ferris, RG Thomas, PS Aisen, DA Bennett, ... Archives of neurology 61 (1), 59-66, 2004 | 1258 | 2004 |
| The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity L Hansen, D Salmon, D Galasko, E Masliah, R Katzman, R DeTeresa, ... Neurology 40 (1), 1-1, 1990 | 1190 | 1990 |
| Rehabilitation of hemiparesis after stroke with a mirror EL Altschuler, SB Wisdom, L Stone, C Foster, D Galasko, DME Llewellyn, ... The Lancet 353 (9169), 2035-2036, 1999 | 997 | 1999 |
| Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease R Motter, C Vigo‐Pelfrey, D Kholodenko, R Barbour, K Johnson‐Wood, ... Annals of Neurology: Official Journal of the American Neurological …, 1995 | 964 | 1995 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 958 | 2017 |
| The Alzheimer's disease centers' Uniform Data Set (UDS): The neuropsychologic test battery S Weintraub, D Salmon, N Mercaldo, S Ferris, NR Graff-Radford, H Chui, ... Alzheimer Disease & Associated Disorders 23 (2), 91-101, 2009 | 922 | 2009 |